A detailed history of Lazard Asset Management LLC transactions in Embecta Corp. stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,675 shares of EMBC stock, worth $53,728. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,675
Holding current value
$53,728
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.46 - $16.56 $42,115 - $60,857
3,675 New
3,675 $51,000
Q3 2023

Nov 14, 2023

SELL
$15.0 - $22.17 $19,905 - $29,419
-1,327 Reduced 53.97%
1,132 $17,000
Q2 2023

Aug 14, 2023

SELL
$21.6 - $30.69 $340,826 - $484,257
-15,779 Reduced 86.52%
2,459 $53,000
Q1 2023

May 15, 2023

BUY
$23.07 - $32.77 $420,750 - $597,659
18,238 New
18,238 $512,000
Q3 2022

Nov 14, 2022

BUY
$24.0 - $33.42 $26,184 - $36,461
1,091 Added 54550.0%
1,093 $31,000
Q2 2022

Aug 09, 2022

BUY
$24.78 - $33.36 $49 - $66
2 New
2 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $846M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.